epidemiologyЭпидемиология и ВакцинопрофилактикаEpidemiology and Vaccinal Prevention2073-30462619-0494«Numicom» LLC10.31631/2073-3046-2022-21-4-113-118epidemiology-1618Research ArticleОБЗОРREVIEWАнализ проблемы массового отказа от вакцинации против COVID-19. Возможные пути решенияAnalyzing the Problem of Mass Rejection of Vaccination against COVID-19. Possible Solutionshttps://orcid.org/0000-0003-3461-3246КорсакЕ. С.KorsakK. S.

Екатерина Сергеевна Корсак – ассистент кафедры инфекционных болезней

г. Гомель

Katsiaryna S. Korsak – assistant of the infectious diseases department

Gomel

Casia28@mail.ruhttps://orcid.org/0000-0002-9435-6109ВоропаевЕ. В.VoropaevE. V.

Евгений Викторович Воропаев – к. м. н., доцент, проректор по научной работе

г. Гомель

Evgenii V. Voropaev – Cand. Sci. (Med.), Docent of Psychology Associate Professor (Docent), Vice-rector for scientific work

Gomel

evoropaev@mail.ruhttps://orcid.org/0000-0003-0483-7329СтомаИ. О.StomaI. O.

Игорь Олегович Стома – д. м. н., доцент, ректор

г. Гомель

Igor O. Stoma - Dr. Sci. (Med.), Associate Professor, Rector

Gomel

rektor@gsmu.byУО «Гомельский государственный медицинский университет»БеларусьGomel State Medical UniversityBelarus202215092022214113118Copyright © Корсак Е.С., Воропаев Е.В., Стома И.О., 20222022Корсак Е.С., Воропаев Е.В., Стома И.О.Korsak K.S., Voropaev E.V., Stoma I.O.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.epidemvac.ru/jour/article/view/1618

Актуальность. Первый случай COVID-19 был зарегистрирован в декабре 2019 г. Спустя несколько месяцев инфекция приобрела статус пандемии. Единственным сдерживающим фактором распространения вируса SARS-CoV-2 является массовая вакцинация, которая позволяет сформировать коллективный иммунитет. Однако достичь высокого охвата прививками не всегда удается. В обзоре рассмотрены основные барьеры на пути массовой вакцинации против COVID-19, обозначены категории людей исходя из их готовности привиться, а также заданы возможные направления работы по преодолению выявленных барьеров. Цель. Проанализировать проблему массового отказа от вакцинации против COVID-19. Обозначить возможные пути решения проблемы. Заключение. Основная причина отказа от вакцинации против COVID-19 – недостаточная информированность населения о безопасности и эффективности вакцин. В данном обзоре перечислены возможные подходы к созданию благоприятной информационной среды, а также способы стимулирования граждан для ускорения темпов массовой вакцинации.

Relevance. The first case of COVID-19 was registered in 2019. Several months later, the local outbreak became pandemic. The only way to curb the spread of SARS-CoV-2 infection is mass vaccination that aims to form a herd immunity. The success of vaccination depends on people’s acceptance, which might be problematic. The review summarizes the main barriers to mass vaccination against COVID-19, categorizing people based on their willingness to vaccinate, and pointing out possible areas of work to overcome the barriers listed above. Aim. Analyze the problem of mass rejection of vaccination against COVID-19. Determine possible solutions. Conclusion. The main reason for refusal to vaccinate against COVID-19 is the lack of public awareness about the safety and efficacy of vaccines. This review lists possible approaches to creating a supportive information environment and ways to stimulate citizens to accelerate the rates of mass vaccination.

вакцинацияиммунопрофилактикаохват вакцинациейприверженность вакцинацииCOVID-19SARSCoV-2отказ от вакцинацииvaccinationpreventionvaccination coveragevaccines acceptanceCOVID-19SARS-CoV-2vaccination adherenceconspiracy theoriesReferencesJin Q, Raza SH, Yousaf M, et al. Can communication strategies combat COVID-19 vaccine hesitancy with trade-off between public service messages and public skepticism? Experimental Evidence from Pakistan. Vaccines. 2021;9(7):757 doi:10.3390/vaccines9070757Jin Q, Raza SH, Yousaf M, et al. Can communication strategies combat COVID-19 vaccine hesitancy with trade-off between public service messages and public skepticism? Experimental Evidence from Pakistan. Vaccines. 2021;9(7):757 doi:10.3390/vaccines9070757Mazraani M, Barbari A. Anti-Coronavirus Disease 2019 Vaccines: Need for Informed Consent. Experimental and Clinical Transplantation. 2021;19(8):753–62. doi: 10.6002/ect.2021.0235Mazraani M, Barbari A. Anti-Coronavirus Disease 2019 Vaccines: Need for Informed Consent. Experimental and Clinical Transplantation. 2021;19(8):753–62. doi: 10.6002/ect.2021.0235Patel SP, Patel GS, Suthar JV. Inside the story about the research and development of COVID-19 vaccines. Clinical and Experimental Vaccine Research. 2021;10(2):154–70.doi: 10.7774/cevr.2021.10.2.154Patel SP, Patel GS, Suthar JV. Inside the story about the research and development of COVID-19 vaccines. Clinical and Experimental Vaccine Research. 2021;10(2):154–70.doi: 10.7774/cevr.2021.10.2.154Brüssow H. COVID-19: vaccination problems. Environmental Microbiology. 2021;23(6):2878–90. doi: 10.1111/1462-2920.15549Brüssow H. COVID-19: vaccination problems. Environmental Microbiology. 2021;23(6):2878–90. doi: 10.1111/1462-2920.15549Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. A new study unpacks the complexities of COVID-19 vaccine hesitancy and acceptance across low-, middle- and high-income countries. Nature Medicine. 2021;27(8):1338–9.doi: 10.1038/s41591-021-01459-7Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. A new study unpacks the complexities of COVID-19 vaccine hesitancy and acceptance across low-, middle- and high-income countries. Nature Medicine. 2021;27(8):1338–9.doi: 10.1038/s41591-021-01459-7Mondal P, Sinharoy A, Su L. Sociodemographic predictors of COVID-19 vaccine acceptance: a nationwide US-based survey study. Public Health. 2021;198:252–9.doi: 10.1016/j.puhe.2021.07.028Mondal P, Sinharoy A, Su L. Sociodemographic predictors of COVID-19 vaccine acceptance: a nationwide US-based survey study. Public Health. 2021;198:252–9.doi: 10.1016/j.puhe.2021.07.028Khan M, Adil SF, Alkhathlan HZ, et al. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules. 2020;26(1):E39. doi: 10.3390/molecules 26010039Khan M, Adil SF, Alkhathlan HZ, et al. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules. 2020;26(1):E39. doi: 10.3390/molecules 26010039Superio DL, Anderson KL, Oducado RMF, et al. The information-seeking behavior and levels of knowledge, precaution, and fear of college students in Iloilo, Philippines amidst the COVID-19 pandemic. International Journal of Disaster Risk Reduction. 2021;62:102414.doi: 10.1016/j.ijdrr.2021.102414Superio DL, Anderson KL, Oducado RMF, et al. The information-seeking behavior and levels of knowledge, precaution, and fear of college students in Iloilo, Philippines amidst the COVID-19 pandemic. International Journal of Disaster Risk Reduction. 2021;62:102414.doi: 10.1016/j.ijdrr.2021.102414Strizova Z, Smetanova J, Bartunkova J, et al. Principles and Challenges in anti-COVID-19 Vaccine Development. International Archives of Allergy and Immunology. 2021;182(4):339–49. doi: 10.1159/000514225Strizova Z, Smetanova J, Bartunkova J, et al. Principles and Challenges in anti-COVID-19 Vaccine Development. International Archives of Allergy and Immunology. 2021;182(4):339–49. doi: 10.1159/000514225Rodriguez-Morales AJ, Franco OH. Public trust, misinformation and COVID-19 vaccination willingness in Latin America and the Caribbean: today’s key challenges. The Lancet Regional Health – Americas. 2021;3. doi: 10.1016/j.lana.2021.100073Rodriguez-Morales AJ, Franco OH. Public trust, misinformation and COVID-19 vaccination willingness in Latin America and the Caribbean: today’s key challenges. The Lancet Regional Health – Americas. 2021;3. doi: 10.1016/j.lana.2021.100073Kordyukova LV, Shanko AV. COVID-19: Myths and Reality. Biochemistry (Mosc). 2021;86(7):800–17. ISSN 00062979. doi: 10.1134/S0006297921070026Kordyukova LV, Shanko AV. COVID-19: Myths and Reality. Biochemistry (Mosc). 2021;86(7):800–17. ISSN 00062979. doi: 10.1134/S0006297921070026Bendau A, Plag J, Petzold MB, et al. COVID-19 vaccine hesitancy and related fears and anxiety. International Immunopharmacology. 2021;97:107724. doi: 10.1016/j.intimp.2021.107724Bendau A, Plag J, Petzold MB, et al. COVID-19 vaccine hesitancy and related fears and anxiety. International Immunopharmacology. 2021;97:107724. doi: 10.1016/j.intimp.2021.107724Do TVC, Thota Kammili S, Reep M, et al. COVID-19 Vaccine Acceptance Among Rural Appalachian Healthcare Workers (Eastern Kentucky/West Virginia): A Cross-Sectional Study. Cureus. 2021;13(8):e16842. doi: 10.7759/cureus.16842Do TVC, Thota Kammili S, Reep M, et al. COVID-19 Vaccine Acceptance Among Rural Appalachian Healthcare Workers (Eastern Kentucky/West Virginia): A Cross-Sectional Study. Cureus. 2021;13(8):e16842. doi: 10.7759/cureus.16842Sturgis P, Brunton-Smith I, Jackson J. Trust in science, social consensus and vaccine confidence. Nature Human Behaviour. 2021;5(11):1528–34. doi: 10.1038/s41562-021-01115-7Sturgis P, Brunton-Smith I, Jackson J. Trust in science, social consensus and vaccine confidence. Nature Human Behaviour. 2021;5(11):1528–34. doi: 10.1038/s41562-021-01115-7Milman O, Yelin I, Aharony N, et al. Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals. Nature Medicine. 2021;27(8):1367–9. doi: 10.1038/s41591-021-01407-5Milman O, Yelin I, Aharony N, et al. Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals. Nature Medicine. 2021;27(8):1367–9. doi: 10.1038/s41591-021-01407-5Solís Arce JS, Warren SS, Meriggi NF, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nature Medicine. 2021;27(8):1385–94. doi: 10.1038/s41591-021-01454-ySolís Arce JS, Warren SS, Meriggi NF, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nature Medicine. 2021;27(8):1385–94. doi: 10.1038/s41591-021-01454-yPaul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health Europe. 2021;1:100012. doi: 10.1016/j.lanepe.2020.100012Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. The Lancet Regional Health Europe. 2021;1:100012. doi: 10.1016/j.lanepe.2020.100012Savulescu J, Pugh J, Wilkinson D. Balancing incentives and disincentives for vaccination in a pandemic. Nature Medicine. 2021;27(9):1500–3. doi: 10.1038/s41591-021-01466-8Savulescu J, Pugh J, Wilkinson D. Balancing incentives and disincentives for vaccination in a pandemic. Nature Medicine. 2021;27(9):1500–3. doi: 10.1038/s41591-021-01466-8Abdulla ZA, Al-Bashir SM, Al-Salih NS, et al. A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development. Pathogens. 2021;10(7):788. doi: 10.3390/pathogens10070788Abdulla ZA, Al-Bashir SM, Al-Salih NS, et al. A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development. Pathogens. 2021;10(7):788. doi: 10.3390/pathogens10070788Bloom DE, Cadarette D, Ferranna M, et al. How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis. Health Affairs (Millwood). 2021;40(3):410–8. doi: 10.1377/hlthaff.2020.02012Bloom DE, Cadarette D, Ferranna M, et al. How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis. Health Affairs (Millwood). 2021;40(3):410–8. doi: 10.1377/hlthaff.2020.02012Tregoning JS, Flight KE, Higham SL, et al. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nature Reviews Immunology. 2021;21(10):626–36. doi: 10.1038/s41577-021-00592-1Tregoning JS, Flight KE, Higham SL, et al. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nature Reviews Immunology. 2021;21(10):626–36. doi: 10.1038/s41577-021-00592-1Shahzamani K, Mahmoudian F, Ahangarzadeh S, et al. Vaccine design and delivery approaches for COVID-19. International Immunopharmacology. 2021;100:108086. doi: 10.1016/j.intimp.2021.108086Shahzamani K, Mahmoudian F, Ahangarzadeh S, et al. Vaccine design and delivery approaches for COVID-19. International Immunopharmacology. 2021;100:108086. doi: 10.1016/j.intimp.2021.108086COVID-19 vaccine tracker and landscape [Internet]. World Health Organization (WHO). Available at: https:.www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines Accessed: 1 January 2022.COVID-19 vaccine tracker and landscape [Internet]. World Health Organization (WHO). Available at: https:.www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines Accessed: 1 January 2022.Yin F, Wu Z, Xia X, et al. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China. Journal of Medical Internet Research. 2021;23(1):e26089. doi: 10.2196/26089Yin F, Wu Z, Xia X, et al. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China. Journal of Medical Internet Research. 2021;23(1):e26089. doi: 10.2196/26089Babicki M, Mastalerz-Migas A. Attitudes toward Vaccination against COVID-19 in Poland. A Longitudinal Study Performed before and Two Months after the Commencement of the Population Vaccination Programme in Poland. Vaccines. 2021;9(5):503. doi: 10.3390/vaccines9050503Babicki M, Mastalerz-Migas A. Attitudes toward Vaccination against COVID-19 in Poland. A Longitudinal Study Performed before and Two Months after the Commencement of the Population Vaccination Programme in Poland. Vaccines. 2021;9(5):503. doi: 10.3390/vaccines9050503Cascini F, Pantovic A, Al-Ajlouni Y, et al. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review. EClinicalMedicine. 2021;40:101113. doi: 10.1016/j.eclinm.2021.101113Cascini F, Pantovic A, Al-Ajlouni Y, et al. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review. EClinicalMedicine. 2021;40:101113. doi: 10.1016/j.eclinm.2021.101113Dratva J, Wagner A, Zysset A, et al. To Vaccinate or Not to Vaccinate-This Is the Question among Swiss University Students. International Journal of Environmental Research and Public Health. 2021;18(17):9210. doi: 10.3390/ijerph18179210Dratva J, Wagner A, Zysset A, et al. To Vaccinate or Not to Vaccinate-This Is the Question among Swiss University Students. International Journal of Environmental Research and Public Health. 2021;18(17):9210. doi: 10.3390/ijerph18179210Sharfstein JM, Callaghan T, Carpiano RM, et al. Uncoupling vaccination from politics: a call to action. The Lancet. 2021;398(10307):1211–2. doi: 10.1016/S0140-6736(21)02099-7Sharfstein JM, Callaghan T, Carpiano RM, et al. Uncoupling vaccination from politics: a call to action. The Lancet. 2021;398(10307):1211–2. doi: 10.1016/S0140-6736(21)02099-7Argote P, Barham E, Daly SZ, et al. The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America. NPJ Vaccines. 2021;6(1):1–9. doi: 10.1038/s41541-021-00380-xArgote P, Barham E, Daly SZ, et al. The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America. NPJ Vaccines. 2021;6(1):1–9. doi: 10.1038/s41541-021-00380-xHromatko I, Tonković M, Vranic A. Trust in Science, Perceived Vulnerability to Disease, and Adherence to Pharmacological and Non-pharmacological COVID-19 Recommendations. Frontiers Psychology. 2021;12:664554. doi: 10.3389/fpsyg.2021.664554Hromatko I, Tonković M, Vranic A. Trust in Science, Perceived Vulnerability to Disease, and Adherence to Pharmacological and Non-pharmacological COVID-19 Recommendations. Frontiers Psychology. 2021;12:664554. doi: 10.3389/fpsyg.2021.664554Zhang Y, Fisk RJ. Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Global Health Journal. 2021;5(1):51–5. doi: 10.1016/j.glohj.2021.02.005Zhang Y, Fisk RJ. Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Global Health Journal. 2021;5(1):51–5. doi: 10.1016/j.glohj.2021.02.005Atehortua NA, Patino S. COVID-19, a tale of two pandemics: novel coronavirus and fake news messaging. Health Promotion International. 2021;36(2):524–34. doi: 10.1093/heapro/daaa140Atehortua NA, Patino S. COVID-19, a tale of two pandemics: novel coronavirus and fake news messaging. Health Promotion International. 2021;36(2):524–34. doi: 10.1093/heapro/daaa140Douglas KM. COVID-19 conspiracy theories. Group Processes & Intergroup Relations. 2021;24(2):270-275. doi: 10.1177/1368430220982068Douglas KM. COVID-19 conspiracy theories. Group Processes & Intergroup Relations. 2021;24(2):270-275. doi: 10.1177/1368430220982068Suthaharan P, Reed EJ, Leptourgos P, et al. Paranoia and belief updating during the COVID-19 crisis. Nature Human Behaviour. 2021;5(9):1190–202. doi: 10.1038/s41562-021-01176-8Suthaharan P, Reed EJ, Leptourgos P, et al. Paranoia and belief updating during the COVID-19 crisis. Nature Human Behaviour. 2021;5(9):1190–202. doi: 10.1038/s41562-021-01176-8Freeman D, Loe BS, Yu LM, et al. Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial. The Lancet Public Health. 2021;6(6):e416–27. doi: 10.1016/S2468-2667(21)00096-7Freeman D, Loe BS, Yu LM, et al. Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial. The Lancet Public Health. 2021;6(6):e416–27. doi: 10.1016/S2468-2667(21)00096-7Sajjadi NB, Shepard S, Ottwell R, et al. Examining the Public’s Most Frequently Asked Questions Regarding COVID-19 Vaccines Using Search Engine Analytics in the United States: Observational Study. Journal of Medical Internet Research Infodemiology. 2021;1(1):e28740. doi: 10.2196/28740Sajjadi NB, Shepard S, Ottwell R, et al. Examining the Public’s Most Frequently Asked Questions Regarding COVID-19 Vaccines Using Search Engine Analytics in the United States: Observational Study. Journal of Medical Internet Research Infodemiology. 2021;1(1):e28740. doi: 10.2196/28740de Figueiredo A, Larson HJ. Exploratory study of the global intent to accept COVID-19 vaccinations. Communications Medicine. 2021;1(1):1–10. doi: 10.1038/s43856-021-00027-xde Figueiredo A, Larson HJ. Exploratory study of the global intent to accept COVID-19 vaccinations. Communications Medicine. 2021;1(1):1–10. doi: 10.1038/s43856-021-00027-xKreps S, Dasgupta N, Brownstein JS, et al. Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation. NPJ Vaccines. 2021;6(1):73. doi: 10.1038/s41541-021-00335-2Kreps S, Dasgupta N, Brownstein JS, et al. Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation. NPJ Vaccines. 2021;6(1):73. doi: 10.1038/s41541-021-00335-2Al-Qerem W, Jarab AS, Qarqaz R, et al. Attitudes of a sample of Jordanian young adults toward different available COVID-19 vaccines. Vaccines. 2021. doi:10.1016/j.vacun.2021.07.008Al-Qerem W, Jarab AS, Qarqaz R, et al. Attitudes of a sample of Jordanian young adults toward different available COVID-19 vaccines. Vaccines. 2021. doi:10.1016/j.vacun.2021.07.008Townsel C, Moniz MH, Wagner AL, et al. COVID-19 vaccine hesitancy among reproductive-aged female tier 1A healthcare workers in a United States Medical Center. Journal of Perinatology. 2021;41(10):2549–51. doi: 10.1038/s41372-021-01173-9Townsel C, Moniz MH, Wagner AL, et al. COVID-19 vaccine hesitancy among reproductive-aged female tier 1A healthcare workers in a United States Medical Center. Journal of Perinatology. 2021;41(10):2549–51. doi: 10.1038/s41372-021-01173-9Haeder SF. Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic. Vaccine. 2021;39(17):2375–85. doi: 10.1016/j.vaccine.2021.03.055Haeder SF. Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic. Vaccine. 2021;39(17):2375–85. doi: 10.1016/j.vaccine.2021.03.055Magadmi RM, Kamel FO. Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia. BMC Public Health. 2021;21(1):1438. doi: 10.1186/s12889-021-11501-5Magadmi RM, Kamel FO. Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia. BMC Public Health. 2021;21(1):1438. doi: 10.1186/s12889-021-11501-5Temsah MH, Barry M, Aljamaan F, et al. Adenovirus and RNA-based COVID-19 vaccines’ perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey. BMJ Open. 2021;11(6):e048586. doi: 10.1136/bmjopen-2020-048586Temsah MH, Barry M, Aljamaan F, et al. Adenovirus and RNA-based COVID-19 vaccines’ perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey. BMJ Open. 2021;11(6):e048586. doi: 10.1136/bmjopen-2020-048586Rzymski P, Zeyland J, Poniedziałek B, et al. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland. Vaccines (Basel). 2021;9(4):382. doi: 10.3390/vaccines9040382Rzymski P, Zeyland J, Poniedziałek B, et al. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland. Vaccines (Basel). 2021;9(4):382. doi: 10.3390/vaccines9040382Wong RSY. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects. Malaysian Journal of Pathology. 2021;43(2):203–17.Wong RSY. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects. Malaysian Journal of Pathology. 2021;43(2):203–17.Mahmud S, Mohsin M, Khan IA, et al. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh. PLOS ONE. 2021;16(9):e0257096. doi: 10.1371/journal.pone.0257096Mahmud S, Mohsin M, Khan IA, et al. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh. PLOS ONE. 2021;16(9):e0257096. doi: 10.1371/journal.pone.0257096Clift AK, von Ende A, Tan PS, et al. Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort. Thorax. 2022;77(1):65–73. doi: thorax.bmj.com/content/77/1/65Clift AK, von Ende A, Tan PS, et al. Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort. Thorax. 2022;77(1):65–73. doi: thorax.bmj.com/content/77/1/65Reddy RK, Charles WN, Sklavounos A, et al. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. Journal of medical virology. 2021;93(2):1045–56. doi: 10.1002/jmv.26389Reddy RK, Charles WN, Sklavounos A, et al. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. Journal of medical virology. 2021;93(2):1045–56. doi: 10.1002/jmv.26389Jackson SE, Paul E, Brown J, et al. Negative vaccine attitudes and intentions to vaccinate against COVID-19 in relation to smoking status: a population survey of UK adults. Nicotine & Tobacco Research. 2021;23(9):1623–8. doi: 10.1093/ntr/ntab039Jackson SE, Paul E, Brown J, et al. Negative vaccine attitudes and intentions to vaccinate against COVID-19 in relation to smoking status: a population survey of UK adults. Nicotine & Tobacco Research. 2021;23(9):1623–8. doi: 10.1093/ntr/ntab039Merkley E, Loewen PJ. Anti-intellectualism and the mass public’s response to the COVID-19 pandemic. Nature Human Behaviour. 2021;5(6):706–15. doi: 10.1038/s41562-021-01112-wMerkley E, Loewen PJ. Anti-intellectualism and the mass public’s response to the COVID-19 pandemic. Nature Human Behaviour. 2021;5(6):706–15. doi: 10.1038/s41562-021-01112-wIoannidis JPA. Benefit of COVID-19 vaccination accounting for potential risk compensation. NPJ Vaccines. 2021;6(1):99. doi: 10.1038/s41541-021-00362-zIoannidis JPA. Benefit of COVID-19 vaccination accounting for potential risk compensation. NPJ Vaccines. 2021;6(1):99. doi: 10.1038/s41541-021-00362-zRomer D, Jamieson KH. Patterns of media use, strength of belief in COVID-19 conspiracy theories, and the prevention of COVID-19 from march to july 2020 in the United States: Survey study. Journal of Medical Internet Research. 2021;23(4):e25215. doi: 10.2196/25215Romer D, Jamieson KH. Patterns of media use, strength of belief in COVID-19 conspiracy theories, and the prevention of COVID-19 from march to july 2020 in the United States: Survey study. Journal of Medical Internet Research. 2021;23(4):e25215. doi: 10.2196/25215Petherick A, Goldszmidt R, Andrade EB, et al. A worldwide assessment of changes in adherence to COVID-19 protective behaviours and hypothesized pandemic fatigue. Nature Human Behaviour. 2021;5(9):1145–60. doi: 10.1038/s41562-021-01181-xPetherick A, Goldszmidt R, Andrade EB, et al. A worldwide assessment of changes in adherence to COVID-19 protective behaviours and hypothesized pandemic fatigue. Nature Human Behaviour. 2021;5(9):1145–60. doi: 10.1038/s41562-021-01181-xSimas C, Larson HJ. Overcoming vaccine hesitancy in low-income and middle-income regions. Nature Reviews Disease Primers. 2021;7(1):1–2. doi: 10.1038/s41572-021-00279-wSimas C, Larson HJ. Overcoming vaccine hesitancy in low-income and middle-income regions. Nature Reviews Disease Primers. 2021;7(1):1–2. doi: 10.1038/s41572-021-00279-wBulley A, Schacter DL. Risks, real and imagined. Nature Aging. 2021;1(8):628–30. doi: 10.1038/s43587-021-00097-5Bulley A, Schacter DL. Risks, real and imagined. Nature Aging. 2021;1(8):628–30. doi: 10.1038/s43587-021-00097-5Mach KJ, Salas Reyes R, Pentz B, et al. News media coverage of COVID-19 public health and policy information. Humanities and Social Sciences Communications. 2021;8(1):1–11. doi: 10.1057/s41599-021-00900-zMach KJ, Salas Reyes R, Pentz B, et al. News media coverage of COVID-19 public health and policy information. Humanities and Social Sciences Communications. 2021;8(1):1–11. doi: 10.1057/s41599-021-00900-zAdepoju P. Public-health authority es in Africa are keen to share positive stories from places where the rollout is going well. Nature Medicine. 2021;27:1122-5 doi: 10.1038/s41591-021-01426-2Adepoju P. Public-health authority es in Africa are keen to share positive stories from places where the rollout is going well. Nature Medicine. 2021;27:1122-5 doi: 10.1038/s41591-021-01426-2Angelo AT, Alemayehu DS, Dachew AM. Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021. PLOS ONE. 2021;16(9):e0257109. doi: 10.1371/journal. pone.0257109Angelo AT, Alemayehu DS, Dachew AM. Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021. PLOS ONE. 2021;16(9):e0257109. doi: 10.1371/journal. pone.0257109Drury J, Carter H, Ntontis E, et al. Public behaviour in response to the COVID-19 pandemic: understanding the role of group processes. The British Journal of Psychiatry. 2020;7(1):e11. doi: 10.1192/bjo.2020.139Drury J, Carter H, Ntontis E, et al. Public behaviour in response to the COVID-19 pandemic: understanding the role of group processes. The British Journal of Psychiatry. 2020;7(1):e11. doi: 10.1192/bjo.2020.139

The authors declare that there are no conflicts of interest present.